18 小时之前
Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
临床结果上市批准突破性疗法
2024-10-30
高管变更
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T™ Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)
免疫疗法快速通道细胞疗法AACR会议
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
快速通道孤儿药细胞疗法临床结果
BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests
引进/卖出诊断试剂
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
孤儿药放射疗法
Dewpoint Therapeutics Announces Nomination of First C-Mod Development Candidate DPTX3186 for Treatment of Wnt-Driven Cancers
临床研究
2024-10-30
引进/卖出siRNA并购
2024-10-30
上市批准
EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema
临床结果
全球快讯
3 小时之前
Alnylam放弃2型糖尿病RNAi
财报临床2期
3 小时之前
复宏汉霖又一款生物类似药在美国申请上市
生物类似药上市批准临床3期临床1期
4 小时之前
正大集团首次试水收购A股上市公司
并购诊断试剂
4 小时之前
遭罗氏退货,UCB抗tau阿尔茨海默病2期临床未达到主要终点
临床结果临床2期抗体药物偶联物
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。